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ABSTRACT
Cancer cells are much more prone to mutations than normal cells, generating over time,
more genetic variants of themselves within the tissue. Drugs designed for one variant
might not work as intended for other variants. As such, effective drug design requires
estimation of proportion of various cancer subpopulations.
In this work, a mixture model based approach with expectation maximization is pro-
posed for determination of cancer heterogeneity. We exploit the pathway knowledge col-
lected by biologists over time to surpass the limitations of identifiability shown by mixture
models. Also in cases where Expectation-Maximization converges to more than one solu-
tion, pathway knowledge is used to break the tie by defining an error metric. Finally, using
experimental data, changes in composition of the mixture over time are estimated using
the model. The approach can also be used to compare the effectiveness of different drugs
on a heterogeneous cancer tissue by observing the response over time.
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1. INTRODUCTION AND LITERATURE REVIEW
1.1 Cancer Heterogeneity
Cancer development occurs when a normal cell evolves to develop some kind of escape
from normal cellular growth control which provides it with a selective growth advantage
[3] [4]. Repeated division of such a cell forms tumors that can invade nearby tissues and
even spawn metastases. Moreover, the cancerous cells are more likely to develop further
mutations compared to normal cells leading to the development of different types of cancer
subpopulations within the same tissue [3]. This phenomenon, termed cancer heterogene-
ity, renders the treatment by a single drug generally ineffective. A "cocktail approach" in
cancer drug design could benefit from an estimation of the relative prevalence of the dif-
ferent subpopulations. Information about the relative ratio of the different subpopulations
when observed over time also can provide a quantitative measure to compare the effective-
ness of different drug combinations on any given cancerous tissue [2]. Hence, modelling
cancer heterogeneity holds promise for designing more effective drug combinations.
1.2 Maximum Likelihood and Expectation-Maximization
Maximum likelihood (ML) estimation refers to estimating the model parameters for
which the observed data are most likely. An obvious approach to calculate the ML esti-
mate is to set the partial derivatives of the likelihood with respect to the parameters to zero.
However, in the case of mixture models, this approach is not well-posed typically because
the likelihood function involves the sum of variables inside the logarithmic function. To
overcome this problem, numerical algorithms like Newton-Raphson method or gradient-
descent can be applied but it usually requires calculation of first and second order deriva-
tives of the likelihood function. This is not possible when the model has hidden variables.
Even, in the case of models without hidden variables, Expectation-Maximization [5],[6]
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provides a simpler, more robust and easy to implement approach to estimating the max-
imum likelihood value. Here robustness is considered with respect to missing [7] and/or
censored [8],[9] data values. Expectation-Maximization based imputation techniques are
quite effective if missing data is small (usually < 5%).
Each iteration of the EM algorithm consists of two steps: the E-step and the M-step.
The Expectation or E-step calculates the expectation of complete log-likelihood given the
observations and current estimate of parameters. The Maximization or M-step computes
the parameter estimates for the next E-step, by maximizing the expectation computed in
current E-step with respect to the model parameters. By using the Kullback-Leibler diver-
gence as a measure of information gain or entropy, it can be shown that the log-likelihood
never decreases after a combined E-step and M-step [10] and thus convergence is guaran-
teed.
In this work, a mixture model based on Expectation-Maximization is proposed to esti-
mate the relative ratio of different cancer subpopulations. Each subpopulation is assumed
to have a multivariate Gaussian distribution over the observables so that the mixture model
is represented by a sum of Gaussians. This assumption provides clean, closed form ex-
pressions for the E-step and M-step computations [6] leading to performance gains when
compared to Markov Chain Monte-Carlo based techniques. Additionally, being a model-
based learning technique, unlike dynamic Bayesian approach proposed in [2], EM does not
require information about the response of individual subpopulations or the initial mixture
composition while observing the dynamic response (i.e. over time) of the mixture.
One of the limitations of the Expectation-Maximization is the problem of identifiability
[11]. When run over multiple iterations, it is not guaranteed that the ratios will always be
calculated in a particular order. Even if they do, the algorithm by itself cannot identify
the subpopulation corresponding to the estimated parameters. Additionally, although the
convergence is guaranteed, the algorithm might converge to local maxima or saddle points
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when applied to real data, as discussed in [9] leading to inaccurate estimate. We exploit
prior pathway knowledge to overcome these limitations of the EM algorithm.
1.3 Pathway Knowledge
Over a long period of time biologists have collected a wealth of information regard-
ing marginal regulatory interactions within a cell, called pathway knowledge. Unfortu-
nately, this information usually gets ignored in most regulatory network models. In a
recent work [12], the authors exploited marginal pathway knowledge to systematically
generate Boolean networks using Karnaugh maps. In this work, we use this pathway in-
formation to sort the ratios in a fixed order and to choose the correct result from a set of
converging points over multiple iterations of the EM algorithm.
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2. GAUSSIAN MIXTURE MODEL FOR CANCER HETEROGENEITY
2.1 Model Description
We consider a Boolean model of the mitogen-activated protein kinase (MAPK) signal
transduction network proposed in [1] where cancer is represented as a stuck-at fault in the
network as shown in Fig. 2.1.
Consider a hypothetical cancer with three major subpopulations with corresponding
stuck-at faults locations shown in Table 2.1. Let the mixture be exposed to different drug
combinations as shown in Table 2.2. We consider transcription factors FOS-JUN and SP1
as observables of interest for the experiments. We assume that only one transcription factor
is observed for each drug combination. If more than one transcription factor is observed,
we classify it as separate experiments. As will be evident in later sections, each experiment
defines a unique dimension in our multivariate model. Thus, for our classification purposes
any unique (drug combination, observable) pair is considered to be a different experiment.
To measure the activity of a transcription factor we measure the expression of a gene
activated by that transcription factor. For example, cMYC, JUN and BIRC5 are some
genes activated by the transcription factor SP1. We observe the expression of a single
gene for the transcription factor in any given experiment. The reporter genes for each
Table 2.1: Stuck-at fault locations for different subpopulations.
Subpopulation Type of Fault Location
Sub. I Stuck-at one ERK1/2
Sub. II Stuck-at one ERBB2/3
Stuck-at one Raf
Sub. III Stuck-at zero PTEN
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Table 2.2: Drug combinations and reporter genes considered for experiments.
Experiment Exp. I Exp. II Exp. III Exp. IV
Drug AG1024 LY294002 U0126 No
Combination + Lapatinib + U0126 Drugs
Obs. Transcrip. SP1 FOS-JUN SP1 SP1
Factor
Reporter Gene cMYC CRE31 JUN BIRC5
Table 2.3: Binary gene response to drug experiments in Table 2.2 for different subpopula-
tions.
Subpopulation Exp. I Exp. II Exp. III Exp. IV
Sub. I upreg. upreg. upreg. upreg.
Sub. II upreg. downreg. downreg. upreg.
Sub. III downreg. upreg. downreg. upreg.
experiment are listed in the last row of Table 2.2. For each experiment, the binary gene
response of the corresponding observables can be evaluated using the MAPK network
shown in Fig. 2.1. For example, for the first experiment, SP1 is upregulated for the first
and second subpopulations while it is downregulated for the third subpopulation. The
binary responses of the corresponding observables for all the experiments are summarized
in Table 2.3.
In [1], the normalized gene expression ratio is used to measure the activity of the
reported genes, which was modeled as the ratio of two normal random variables, each with
its standard deviation directly proportional to its mean. This modelling, however, requires
the observables to have non-standard prior distribution which leads to non-closed form
expressions for the posterior distribution of the relative ratio parameters. To approximate
these posterior distributions, variational or Markov-chain Monte Carlo (MCMC) methods
5
Figure 2.1: MAPK network with stuck-at faults reproduced from Anwoy [1].
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are used which are prone to error because of the inherent approximations involved.
In this work, we consider non-normalized gene expression ratio observations. We as-
sume that the gene expression is measured as the intensity of light emitted by a specific
fluorescent protein whose production is directly proportional to the expression of the gene
to be observed. Since the gene expression is normally distributed with standard devia-
tion directly proportional to its mean [13] we assume that the normal distribution for the
observed intensity also exhibits this property. This assumption of a normal distribution
facilitates compact vector expression for the posterior distribution and the use of a closed
form expression for parameter values at each iteration of the Expectation-Maximization
algorithm.
We assume that the intensity of the gene activity in a given subpopulation affected by a
drug becomes exactly zero. In reality, however, there might be some feedback network that
prevents the gene expression from becoming exactly zero. Even in those cases, it is safe to
assume that such a subpopulation will have gene expression values significantly different
from that without drug treatment. It is also interesting to note that the work here differs
from that in [2] where binary decisions for observed intensity are used in the algorithm.
Also, unlike [2], observed intensity for individual subpopulations in response to the drugs
is not assumed to be known. Only prior pathway knowledge and drugs causing differential
response of given genes are assumed to be known. This information is used to design
experiments but the algorithm uses continuous intensity values for improved accuracy.
2.2 Gaussian Mixture Model for Cancer Heterogeneity
Assume Ij,k as the unknown mean and c×Ij,k as the standard deviation of the observed
intensity distribution for the kth subpopulation in the jth experiment, where the coefficient
of variation c is considered to be an unknown parameter. Then, with the assumptions as
described above, the observed intensity x1 for the first experiment has the distribution
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defined by the weighted mixture density,
p(x1) = α1N (x1|I1,1, cI1,1) + α2N (x1|I1,2, cI1,2) (2.1)
where α1 : α2 : α3 denotes the relative ratio of three subpopulations in the mixture with
the constraint
α1 + α2 + α3 = 1 (2.2)
Similarly, in the second experiment, FOS-JUN is upregulated in the case of the first
and third subpopulations and downregulated in the case of the second. Therefore, the
probability distribution for the observed intensity x2 is given by,
p(x2) = α1N (x2|I2,1, cI2,1) + α3N (x2|I2,3, cI2,3) (2.3)
The expressions for the other experiments can be obtained in a similar fashion. This
example can be extended to the case when the intensity of the kth subpopulation affected
by the drug is not exactly zero by adding the term αkN (x|I ′j,k, c × I ′j,k) to the mixture
density in the jth experiment. Here I ′j,k is assumed to be a non-zero mean intensity in the
presence of the affecting drug. For compact representation, we introduce the variable µk,j
for the subpopulation k defined as
µj,k = dj,kIj,k + (1− dj,k)I ′j,k (2.4)
where dj,k is a binary value which equals ’1’ if the drug in experiment j does not affect the
observable in subpopulation k, and otherwise the value equals ’0’. The observed intensity
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for the jth experiment can now be expressed in the general form as,
p(xj) =
3∑
k=1
αkN (xj|µj,k, cµj,k) (2.5)
To combine information across all experiments, we can further compact Eq. (2.5) to
vector representation in terms of the multivariate Gaussian distribution as
p(x) =
3∑
k=1
αkN (x|µk,Σk) (2.6)
where x is the column vector [x1, x2, x3, x4]T and N (x|µk,Σk) is a multivariate Gaussian
distribution defined as
N (x|µk,Σk) =
1
(2pi)4/2|Σk|1/2
× exp
(
−1
2
(x− µk)TΣk−1(x− µk)
)
(2.7)
µk is a column vector of means [µ1,k, µ2,k, µ3,k, µ4,k]T for the kth subpopulation given
by
µk = diag
[dk (14×1 − dk)]
Ik
I′k

 (2.8)
where dk is the 4 × 1 binary-valued "expression profile" vector with jth entry dj,k = 1
if corresponding transcription factor is upregulated in jth experiment and zero otherwise.
Here we have assumed that the drugs are kinase-inhibitors which downregulate the af-
fected transcription factor. 14×1 is column vector with all entries as 1. Ik and I′k are 1× 4
column vectors of mean intensity when the transcription factor is upregulated and down-
regulated respectively. Eq. (2.8) is just matrix based notation of Eq. (2.4). The variable
Σk is introduced as a variance-covariance matrix for the kth subpopulation.
The unknown parameters in this model are the weight vector α, mean intensity matrix
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µ and the covariance matrix Σ. These parameters need to be estimated from observed
intensity values x. Expectation-Maximization iteratively updates the parameters in the
direction of increasing likelihood of observed intensity.
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3. EXPECTATION-MAXIMIZATION FOR CANCER HETEROGENEITY
3.1 Mixture Model Representation with Hidden Variables
In this chapter we consider a more generalized case of the example presented in Chap-
ter 2. Consider an ensemble of K subpopulations with J unique (drug combination, ob-
servable) pairs, henceforth referred to as J experiments for simplicity. Let the weight vec-
torα = [α1, ..., αK ] denote the relative ratio of different subpopulations with
∑K
k=1 αk = 1
and αk > 0. From Eq. (2.6), the probability distribution of the ith data point is dependent
on the weight vectorα, the mean intensity matrixµ, the three-dimensional covariance ma-
trix Σ and the expression profile matrix d =[d1,d2, ...,dk]. The conditional probability
distribution of the ith observed data point xi ∈ RJ is given by
p(xi|α,µ,Σ,d) =
K∑
k=1
αkN (xi|µk,Σk,d) (3.1)
Expectation-Maximization is an iterative procedure to maximize the log-likelihood of
above expression. To make the estimation of parameters more tractable, we introduce
hidden data zi to denote hidden assignment of data point xi to one of the subpopulations.
In other words, zi = k means ith observed data point was sampled from kth subpopulation.
This information is not directly observed and hence the term "hidden". Assume zi are
modeled as discrete random variables Zi ∈ {1, 2, ..., K}, i.e. zi is a realization of random
variable Zi. Assuming xi as a realization of the continuous random variable Xi, the joint
probability over the "complete data set" Yi = (Xi, Zi) including both observed and hidden
data is given by
p(yi|α,µ,Σ,d) = p(xi, zi|α,µ,Σ,d) = P (zi|µ,Σ,d)p(xi|zi,µ,Σ,d) (3.2)
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Since p(xi|zi,µ,Σ,d) is assumed to be normally distributed with mean µzi and standard
deviation Σzi , we have
p(yi|α,µ,Σ,d) = P (zi|µ,Σ,d)N (xi|zi,µ,Σ,d) (3.3)
where N (xi|Zi = k,µ,Σ,d) = N (xi|µk,Σk,d). Using the theorem of total probability
the probability distribution of the ith data point is given by marginalizing Eq. (3.3) over
the domain of Zi as
p(xi|α,µ,Σ,d) =
K∑
zi=1
P (zi|µ,Σ,d)N (xi|zi,µ,Σ,d) (3.4)
Note that since Zi is a discrete random variable which denotes which subpopulation each
data point came from, we have P (Zi = k|µ,Σ,d) = αk which verifies that Eq. (3.1)
and (3.4) are equal. However, the benefit of using the latter is that it simplifies the log-
likelihood expression.
3.2 Expectation-Maximization
Expectation-Maximization is an iterative method that tries to maximize the expected
log-likelihood of the complete data Yi using the following iterative procedure: first it
makes a guess about the complete data Yi, then it solves for parameters that maximize
(the expected) log-likelihood of Yi. Once an estimate for parameters is obtained, it is
then used to make a better guess of the complete data Yi, and iterations continue till some
threshold is reached. In the following sections, E-step and M-step are discussed in detail.
3.2.1 E-step
In the E-step, the expected value of the log-likelihood of Yi is calculated from the
conditional probability distribution of Yi given the observation xi and the current estimate
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of parameters. For compactness in representation, let θ = {α,µ,Σ,d} and let θ(t) denote
the estimated parameters at the end of the tth iteration. Then,
EYi|xi,θ(t) [log p(Yi|θ)] =
∫
Y(xi)
log[p(yi|θ)]p(yi|xi,θ(t))dyi (3.5)
where Y(xi) is the support of Yi given xi, i.e. closure of the set {yi|p(yi|xi) > 0)}. Since
the only random part in the complete data Yi is Zi the expectation of p(Yi|µ,Σ,d) can
be calculated over the domain of Z,
EYi|xi,θ(t) [log p(Yi|θ)] = EZi|xi,θ(t) [log p(xi, Zi|θ)]
=
K∑
zi=1
P (zi|xi,θ(t)) log p(xi, zi|θ)
=
K∑
zi=1
p(zi,xi|θ(t))
p(xi|θ(t))
log p(xi, zi|θ)
=
K∑
zi=1
p(yi|θ(t))
p(xi|θ(t))
log p(xi, zi|θ)
=
K∑
k=1
γ
(t)
ik log(αkN (xi|µk,Σk,d))
=
K∑
k=1
γ
(t)
ik
(
logαk − 1
2
log |Σk| − 1
2
(xi − µk)TΣ−1k (xi − µk)
)
(3.6)
where we have ignored the constants in last step and γ(t)ik is defined as
γ
(t)
ik ,
p(zi,xi|θ(t))
p(xi|θ(t))
=
αkN (xi|µk,Σk,d)∑K
k=1 αkN (xi|µk,Σk,d)
(3.7)
Let x denote the collection of allN observations xi taken together modelled as continuous
random variable X. Let Y = (X, Z) where Z is collection of hidden random variables Zi
for all observations. Then, assuming all data points to be i.i.d., it can be shown that the
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expected log-likelihood of p(Y|θ) is given by
EY|x,θ(t) [log p(Y|θ)] =
N∑
i=1
EYi|xi,θ(t) [log p(Yi|θ)] (3.8)
Substituting Eq. (3.6) in (3.8)
EY|x,θ(t) [log p(Y|θ)] =
N∑
i=1
K∑
k=1
γ
(t)
ik
(
logαk − 1
2
log |Σk| − 1
2
(xi − µk)TΣ−1k (xi − µk)
)
(3.9)
3.2.2 M-step
The M-step is to find the parameters that maximize the expectation computed in E-step,
i.e.,
θ(t+1) = arg max
θ
EY|x,θ(t) [log p(Y|θ)]
subject to
K∑
k=1
αk = 1,
αk ≥ 0, k = 1, 2, ..., K,
Σk  0, k = 1, 2, ..., K. (3.10)
where Σk  0 means Σk is positive definite. To find the maximizing parameters, we
need to set partial derivative with respect to each parameter to zero. For ease in partial
differentiation, Eq. (3.9) can be expressed as
EY|x,θ(t) [log p(Y|θ)] =
K∑
k=1
(
N∑
i=1
γ
(t)
ik
)(
logαk − 1
2
log |Σk|
)
−
N∑
i=1
K∑
k=1
1
2
γ
(t)
ik (xi − µk)TΣ−1k (xi − µk)
(3.11)
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Setting partial derivatives of expression in Eq. (3.11) to zero we get
α
(t+1)
k =
∑N
i=1 γ
(t)
ik
N
(3.12)
µ
(t+1)
k =
∑N
i=1 γ
(t)
ik xi∑N
i=1 γ
(t)
ik
(3.13)
Σ
(t+1)
k =
∑N
i=1 γ
(t)
ik (xi − µk)(xi − µk)T∑N
i=1 γ
(t)
ik
(3.14)
3.3 Initialization, Convergence and Exploiting Pathway Knowledge
An important limitation of mixture models in general is the problem of identifiabil-
ity [11], i.e., in a model with K-densities there are K! possible ways of assigning K
parameters to K cancer subpopulations. In case of cancer, the interchange of relative ra-
tios of different subpopulations can be lethal. This problem is addressed by exploiting
the prior pathway knowledge. By comparing the observed mean intensities with the ex-
pression profile vector of each subpopulation, the parameters can be corrrectly matched
to corresponding subpopulations. Moreover, it is important to note that although EM tries
to find peaks in log-likelihood L(θ|x), if the latter has multiple peaks then the algorithm
might converge to local maxima. The convergence is quite sensitive to initializations and
solution might converge to maxima closest to the initial point. To overcome this, we run
the algorithm over multiple initializations and choose correct result by defining an error
metric based on pathway knowledge.
In the next chapter, we present results of estimation of cancer heterogeneity on syn-
thetic and real experiment data. In addition, we employ this algorithm to observe dynamic
behaviour (over time) of mixture of cancer subpopulations. The results are compared with
the case when complete information about individual subpopulations and initial mixture
distribution is known [2].
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4. RESULTS
4.1 Synthetic Data
To validate the algorithm we generated synthetic data for the scenario discussed in
Chapter 2. We assume that when an observable is downregulated, the corresponding ob-
served intensity drops to one fourth of the upregulated intensity. The value of the coeffi-
cient of variation c is taken to be equal to 0.17 and assumed constant for all cases. Exper-
imental studies have verified that typical values of c are close to this [13]. The assumed
mean intensity values for upregulated observables for different experiments are given in
Table 4.1.
Since the intensity values cannot be negative, we set the values generated from normal
distributions around these means to 1000 whenever they are negative. The data was gener-
ated for a total of 100 cells for each experiment with 20 cells from subpopulation I, 30 cells
from subpopulation II and 50 cells from subpopulation III. The algorithm is repeated for
1000 times with different random initial values every time. The calculated ratio is recorded
for each repeat and kernel densities were plotted for the recorded ratios for the mixture as
shown in Fig. 4.1. Since there is a single peak in density, the algorithm converged to
global maxima. The ratio corresponding to the peak was found to be (0.20, 0.30, 0.50).
4.2 Experimental Data
A mixture of three cancer cell lines, A2068, HCT116 and SW480 was prepared in
the ratio (0.15, 0.35, 0.50). The intensity of light was observed over red, blue and green
Table 4.1: Assumed intensity values for generating synthetic data.
Observables cMYC CRE31 JUN BIRC5
Intensity 1× 103 5× 103 1.3× 103 7.6× 103
16
Figure 4.1: Kernel density estimate of relative ratio parameters for synthetic data.
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Table 4.2: Error values of mean intensities for two peaks in Fig. 4.2.
T
∑
j∈downreg genes |Ij1T − Iavgj1 |
∑
j∈downreg genes |Ij2T − Iavgj2 |
1 1142 23.9
2 861 8
3 9 356
Ep 2012 387.9
channels for a group of cells drawn randomly from the mixture. The prior information
provided about each cell line is shown in Table 4.3. The distribution of the calculated
ratios over multiple runs of the EM algorithm are shown in Fig. 4.2. It is evident from the
figure that the EM algorithm converges to two local maximas. To determine, the accurate
composition from these two choices, we can exploit the pathway knowledge. Since the
mixture is untreated, we do not expect sudden changes in the initial hours. Data observed
at time T = 1, T = 2 and T = 3 hours was combined and the resultant mean intensities from
the algorithm were compared against those obtained from each time interval separately.
We defined the error metric Ep of peak p as,
Ep =
3∑
T=1
∑
j∈downreg genes
|IjpT − Iavgjp | (4.1)
where Iavg is the intensity from combined data for initial three hours. Here we chose
downregulated genes only because mean intensity and variance and hence the error would
be less for downregulated genes compared to upregulated genes. The peak with the mini-
mum error Ep is chosen as the final result. From Ep values in Table 4.2 it second peak is
the correct choice. The calculated mean intensities in the second case show least variation
over first three hours.
The mean intensity estimated by the EM algorithm and the corresponding ratios are
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Figure 4.2: Kernel density estimate of relative ratio parameters for real data at time T = 1.
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Table 4.3: Prior pathway knowledge for experimental data in Section 4.2.
Subpopulation Red Channel Green Channel Blue Channel
A2058 downreg. upreg. upreg.
HCT116 upreg downreg. upreg.
SW480 downreg. downreg. upreg.
Table 4.4: Calculated and observed mean intensity values for different observables.
Subpop. Channel Calculated Mean Calculated ratio Observed Mean
R 4.7602 3.5703
Subpop. I G 1.189× 103 0.1785 1.0576× 103
B 9.173× 103 7.0516× 103
R 2.477× 103 2.1739× 103
Subpop. II G 6.0692 0.3531 3.6386
B 1.0247× 104 8.1546× 103
R 0.000 5.8139
Subpop. III G 4.3 0.4684 4.2163
B 9.3755× 103 8.7397× 103
shown in Table 4.4. Comparing the observed mean intensities with pathway knowledge,
we can conclude that subpopulation I, II and III are A2058, HCT116 and SW480 respec-
tively. Thus, we can conclude that the ratio of cell-lines (A2068, HCT116, SW480) is
(0.1785, 0.3531, 0.4684). Also, in Table 4.4 observed mean intensity values of the cell-
lines observed individually are shown for comparison with the calculated ones.
Furthermore, to observe the change in heterogeneity with time, the results of algorithm
at different time instants are shown in Fig. 4.3. To break the tie in cases where multiple
peaks were obtained we used intensities Iavgj2 as metric for comparison, provided in Table
4.5. The variation of calculated intensities of downregulated variables from the standard
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Table 4.5: Calculated average mean intensity values for combined T = 1, 2 and 3.
Subpop. Channel Intensity (×104)
R 0.0051
Subpop. I G 0.1243
B 1.0933
R 0.2356
Subpop. II G 0.0004
B 1.2383
R 0.000
Subpop. III G 0.0004
B 1.1669
in Table 4.5 and corresponding ratios at different time instants are given in Table 4.6. The
results of a recently proposed algorithm [2] when applied on our data are shown in Fig.
4.4. This result was provided by Dr. Chao for comparison purposes. Unlike this work,
the dynamic Bayesian framework based algorithm proposed in [2] assumes that complete
information about each individual subpopulation is known. In other words, the distribution
of intensities and initial mixture proportion are assumed to be known. Comparing Fig. 4.3
and 4.4, it can be seen that even without this information our results closely estimate the
dynamic behaviour predicted with complete information.
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Table 4.6: Variation of mean intensities from standard 4.5 for data observed over time.
T Calculated Ratio Variation of calculated intensities
1 (0.1730, 0.3607, 0.4663) 23.9
5 (0.1628, 0.3775, 0.4596) 15
10 (0.1785, 0.3792, 0.4422) 46
15 (0.1617, 0.3996, 0.4387) 35
20 (0.1639, 0.4199, 0.4162) 16
25 (0.1666, 0.4425, 0.3908) 19
30 (0.1834, 0.4520, 0.3647) 143
35 (0.1956, 0.4627, 0.3417) 205
40 (0.2087, 0.4760, 0.3153) 216
45 (0.2176, 0.4883, 0.2941) 287.7
Figure 4.3: Estimate of relative ratio parameters over time.
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Figure 4.4: Estimate of relative ratio parameters over time using algorithm in [2].
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5. SUMMARY AND CONCLUSIONS
A Gaussian Mixture-Model with Expectation-Maximization was proposed for address-
ing cancer heterogeneity. The working of the algorithm was verified on synthetic and ex-
perimental data. Future work may involve verification on datasets involving drug-treated
mixtures and comparing efficacy of different drugs in killing heterogeneous cancer cell
populations.
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